3D-Printed Composite Resin Restorations: Fabrication and placement of Class II inlay or onlay restorations using 3D-printed composite resin material.
Semi-Direct Composite Resin Restorations: Fabrication and placement of Class II inlay or onlay restorations using the semi-direct composite resin technique
Study summary
This randomized controlled clinical trial aims to evaluate the clinical performance of 3D-printed composite resin restorations compared with semi-direct composite resin restorations in posterior teeth requiring Class II inlay or onlay restorations.
Eligibility
Sex
ALL
Min age
25 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Patients aged 25-40 years.
* Patients requiring two Class II inlay or onlay restorations.
* Teeth with carious lesions or defective restorations requiring indirect restorative treatment.
* Teeth with sufficient structure to receive an inlay/onlay restoration.
Exclusion Criteria:
* Patients with systemic diseases or medical conditions that may affect oral health or healing.
* Pregnant or lactating patients.
* Patients with poor oral hygiene or uncontrolled periodontal disease.
Primary outcome measure(s)
Fracture of restorations — 12 months Clinical evaluation of restoration fracture or bulk failure after placement of 3D-printed composite resin and semi-direct composite resin restorations. at baseline, 6 months, 9 months, and 12 months after restoration placement. using a modified FDI criteria score. All restorations will be evaluated and categorized based on their clinical performance according to the assigned criteria: score 1 indicates a clinically excellent restoration, scores 2 and 3 represent clinically acceptable restorations, while scores 4 and 5 are considered clinically unacceptable. Clinical success will be defined as restorations receiving scores of 1, 2, or 3, whereas scores of 4 or 5 will be considered clinical failures.
Trial sites (1)
Facility
City
Region
Status
Restorative Department, Faculty of Dentistry, Tanta University
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.